Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Behcet Syndrome

• A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
• Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease
• "Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
• Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
• A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
• Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
• Uses of Tacrolimus in Behcet Disease
• A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
• Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
• The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease
• Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers
• Low-dose IL-2 Treatment on Behcet's Disease
• Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis
• Topical Pentoxifylline Gel on Behcet's Disease Oral Ulcers
• Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease
• Anti IL-18 (GSK1070806) in Behcet's Disease
• Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
• Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
• Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation
• 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
• Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
• Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
• A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
• A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
• Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
• Tocilizumab for the Treatment of Behcet's Syndrome
• A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
• Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
• Efficacy of Humira in Behcet Patients With Arthritis
• The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
• A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
• Phase III Study in Refractory Behcet's Disease
• Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
• A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
• Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
• Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
• Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
• Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
• HAT in Eye Complications of Behcet's Disease